Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next-generation inhaled nitric oxide (NO) delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions.


Pharmaceutical

Vero Biotech

Brent Furse

Kyle Galenski

Jeff Dail

Diego Vargas

Kevin Stout

Kevin Dolan

Jeff Bruner

Christopher Dumadag

Molly Gannett Rrt-Nps

Brian Cugliari

Clayton Santiago

Robyn McClure

Jason Molinari

Michael Landis Phr

Kevin Friedman Do

Eric S. Finkelman

Judson Boothe

Namita Khanna

Michelle Nickoli

Nate Pinkard

The Strategic and Regulatory Development team at Vero Biotech is responsible for overseeing the planning and implementation of strategies to advance the company's inhaled nitric oxide delivery systems. This includes ensuring compliance with regulatory standards, optimizing strategic sourcing, managing facility operations, and driving quality assurance to meet the needs of patients with cardiopulmonary conditions.

Strategic and Regulatory Development

Engineering

Sales Team

Strategic and Regulatory Development

About

Team members

Other teams at Vero Biotech

Engineering

Sales Team